| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT04862221 TReatment for ImmUne Mediated PathopHysiology |
Enrollment reduced: 163 -> 44 participants |
| 2026-08-11 | NCT03884075 Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect… |
date change Primary completion pushed: 2026-08-31 -> 2027-09-03 |
| 2026-08-11 | NCT03884075 Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect… |
date change Completion pushed: 2026-10-02 -> 2027-12-31 |
| 2026-07-29 | NCT00739362 Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment |
Enrollment closed, study ongoing |
| 2026-07-29 | NCT00739362 Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment |
Enrollment reduced: 148 -> 126 participants |
| 2026-07-29 | NCT01878045 Mechanisms of Diabetic Kidney Disease in American Indians |
overall status: Suspended → Completed |
| 2026-07-29 | NCT04862221 TReatment for ImmUne Mediated PathopHysiology |
Enrollment closed, study ongoing |
| 2026-07-29 | NCT04862221 TReatment for ImmUne Mediated PathopHysiology |
Trial sites reduced: 24 -> 17 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT03520660 | People With CHC Who Achieved a Sustained Virological Response Following Therapy With… | Diabetes Mellitus | Active, Not Recruiting |
| Phase 3 | |||
| NCT02262832 | Compassionate Use of Metreleptin in Previously Treated People With Generalized… | Lipodystrophy | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07444723 | Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of… | Primary Hyperparathyroidism | Recruiting |
| Phase 2 | |||
| NCT05470504 | Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance | Insulin Receptor Mutation | Recruiting |
| NCT05832229 | Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United… | Cirrhosis | Recruiting |
| NCT04927416 | The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer | Metastic Thyroid Cancer | Recruiting |
| NCT07142252 | Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus | Recruiting |
| NCT02019706 | Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in… | ACTH | Recruiting |
| NCT06092333 | VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B | Chronic Hepatitis B | Recruiting |
| NCT00977977 | Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy | Nephrotic Syndrome | Recruiting |
| NCT03884075 | Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect… | Non-Alcoholic Steatohepatitis | Recruiting |
| NCT06635629 | Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome | Cushing Syndrome | Recruiting |
| NCT03841617 | The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer | Thyroid Cancer | Recruiting |
| NCT00085982 | Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance | Severe Insulin Resistance | Active, Not Recruiting |
| NCT03929601 | Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes | Type 1 Diabetes Mellitus | Active, Not Recruiting |
| NCT07216391 | Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG | Type 1 Diabetes Mellitus | Not Yet Recruiting |
| NCT05743244 | Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1… | Diabetes Mellitus, Type 1 | Active, Not Recruiting |
| NCT07683026 | Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo | Type 1 Diabetes (T1D) | Not Yet Recruiting |
| NCT00739362 | Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment | Electric Stimulation Therapy | Active, Not Recruiting |
| NCT02262806 | Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy | Diabetes | Active, Not Recruiting |
| NCT04862221 | TReatment for ImmUne Mediated PathopHysiology | Acute Liver Failure | Active, Not Recruiting |
| NCT05713799 | Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With… | Insulin Resistance | Not Yet Recruiting |
| NCT07313787 | Effects of Meal Macronutrients on Postprandial Lipids | Nephrotic Syndrome | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06991738 | 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive… | Thyroid Cancer | Not Yet Recruiting |
| Phase 1 | |||
| NCT04799301 | Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake | Diet Therapy | Recruiting |